Cencora price target raised to $300 from $275 at Jefferies

Jefferies raised the firm’s price target on Cencora (COR) to $300 from $275 and keeps a Hold rating on the shares. Progress with the pending reconciliation bill and changes Congress has to make to get it over the line in the next few weeks will continue to drive daily trading for most healthcare provider names in the near-term, the analyst tells investors in a research note. The firm views any improvement vs. the Senate Finance Committee version of Medicaid cuts positively for its coverage universe.